Provisinfusion.com » For Patients https://provisinfusion.com Provis Infusion Clinic Mon, 12 Dec 2022 19:24:19 +0000 en-US hourly 1 http://wordpress.org/?v=3.5.1 Provis Infusion Interactive Tour https://provisinfusion.com/provis-infusion-interactive-tour/ https://provisinfusion.com/provis-infusion-interactive-tour/#comments Tue, 14 Jan 2014 18:39:53 +0000 Graham Vincent http://provisinfusion.com/?p=603 Interested in viewing the Provis Infusion Clinic? Click on the link below to access the interactive tour.

]]> https://provisinfusion.com/provis-infusion-interactive-tour/feed/ 0 Kadcyla® is now offered at the Provis Infusion Clinic https://provisinfusion.com/kadcyla-is-now-offered-at-the-provis-infusion-clinic/ https://provisinfusion.com/kadcyla-is-now-offered-at-the-provis-infusion-clinic/#comments Tue, 14 Jan 2014 18:37:14 +0000 Graham Vincent http://provisinfusion.com/?p=601 Kadcyla® is a single agent for the treatment of people with HER2-positive metastatic breast cancer (mBC) who received both prior treatment with HERCEPTIN® (trastuzumab) and a taxane, separately or in combination.

]]> https://provisinfusion.com/kadcyla-is-now-offered-at-the-provis-infusion-clinic/feed/ 0 Perjeta, Avastin, Herceptin, Kadcyla, Rituxan, Abraxane and Treanda Update for Patients https://provisinfusion.com/herceptin-avastin-and-rituxan-update-for-patients/ https://provisinfusion.com/herceptin-avastin-and-rituxan-update-for-patients/#comments Thu, 14 Mar 2013 19:10:29 +0000 provis http://provis.soxial.com/?p=23 Perjeta, Herceptin, Avastin, Kadcyla, Rituxan, Treanda,Renflexis, and Abraxane patients: Provis fully particpates in the Treanda, Abraxane and Roche Patient Support Program. For qualified Perjeta, Herceptin, Avastin, Kadcyla, Rituxan, Abraxane, Renflexis and Treanda patient financial assistance maybe available.  Please contact Provis for further information.

]]> https://provisinfusion.com/herceptin-avastin-and-rituxan-update-for-patients/feed/ 0 Quick Print – Patient Information https://provisinfusion.com/quick-print-patient-information/ https://provisinfusion.com/quick-print-patient-information/#comments Thu, 14 Mar 2013 18:16:54 +0000 provis http://provis.soxial.com/?p=32 Quick Print Information for Patients:

Patient Information Guide

Contact Information & Map to Location

Patient Information by Product Name:

Abraxane ™ Adcetris ® Alimta ® Avastin® Caelyx ® Carboplatin ® Cisplatin ® Cyramza ® Eloxatin ® Ehnertu ® Empliciti ® Erbitux ® Folotyn ® Gemzar ™ Havalen [...]]]> https://provisinfusion.com/quick-print-patient-information/feed/ 0 Patient Information Guide https://provisinfusion.com/patient-orientation/ https://provisinfusion.com/patient-orientation/#comments Thu, 14 Mar 2013 18:04:31 +0000 provis http://provis.soxial.com/?p=26 Please use the following links to download the new patient guide & map to our clinic:

New Patient Information Guide:

Patient Information Guide

Contact Information & Map to Clinic Location:

Contact Us & Map to Location]]> https://provisinfusion.com/patient-orientation/feed/ 0 Helpful Links & Resources https://provisinfusion.com/helpful-links-resources/ https://provisinfusion.com/helpful-links-resources/#comments Thu, 14 Mar 2013 21:24:34 +0000 provis http://provis.soxial.com/?p=232 Related Links

Canadian Cancer Society Canadian Cancer Society Ontario Chapter Health Canada National Cancer Institute of Canada National Cancer Institute (United States) Ontario Ministry of Health and Long-Term Care Cancer Care Ontario CAREPath Inc.]]> https://provisinfusion.com/helpful-links-resources/feed/ 0 Frequently Asked Questions https://provisinfusion.com/for-patients-faq/ https://provisinfusion.com/for-patients-faq/#comments Thu, 14 Mar 2013 15:15:42 +0000 provis http://provis.soxial.com/?p=13 A: Provis Infusion Clinic accepts patients for infusion services only by referral
from physicians. You can ask your doctor to refer you for treatment at Provis.
Upon receipt of the medical referral form from your doctor, Provis will contact
you about further steps [...]]]> https://provisinfusion.com/for-patients-faq/feed/ 0